Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Wolverine Stack is dominating 2026's recovery trends, but BPC 157 and TB 500 aren't approved for human use and have no place in supplements. As consumers chase drug like results from unregulated products, legitimate FDA moves toward easing restrictions on certain peptides BioPharma Dive